Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1985;72:898-906

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nattel, S.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*AMITRIPTYLINE

Circulation, Vol 72, 898-906, Copyright © 1985 by American Heart Association


ARTICLES

Frequency-dependent effects of amitriptyline on ventricular conduction and cardiac rhythm in dogs

S Nattel

Although overdoses of tricyclic antidepressant are known to produce both sinus tachycardia and ventricular tachyarrhythmias in man, these have been assumed to occur by independent mechanisms. This study was designed to evaluate the relationship of ventricular activation frequency to the cardiotoxic effects of amitriptyline. When amitriptyline was infused into dogs with formalin-induced atrioventricular (AV) block to evaluate a broad range of pacing frequencies, the drug produced dose-related QRS prolongation that was markedly frequency dependent. Similar frequency-dependent depression of the maximum rate of depolarization (Vmax) was noted for canine Purkinje fibers superfused with amitriptyline in vitro. The time constant of recovery from amitriptyline-induced block was dose independent and averaged 228 msec in vivo and 216 msec in vitro. When amitriptyline was infused into dogs with intact AV conduction, sinus tachycardia occurred within 15 min, followed by progressive QRS prolongation and ventricular tachyarrhythmias after an average 29 min. Slowing of sinus rate by vagal stimulation (seven dogs) or intravenous metoprolol (five dogs) reproducibly reversed the QRS prolongation and ventricular tachyarrhythmias caused by amitriptyline. These studies show that amitriptyline produces frequency-related depression of ventricular conduction in vivo, with a time dependence similar to effects on the maximum rate of depolarization in vitro. Interventions that slow heart rate reverse the adverse effects of amitriptyline on ventricular conduction and cardiac rhythm.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. Nau, M. Seaver, S.-Y. Wang, and G. K. Wang
Block of Human Heart hH1 Sodium Channels by Amitriptyline
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1015 - 1023.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
S. Nattel
Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs
Cardiovasc Res, March 1, 1998; 37(3): 567 - 577.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. M. Roden
Risks and Benefits of Antiarrhythmic Therapy
N. Engl. J. Med., September 22, 1994; 331(12): 785 - 791.
[Full Text]